Skip to main content
Log in

Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands

  • Original Articles
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

Since 1974 primary aldosteronism has been diagnosed in 71 patients in our outpatient clinic. Thirty-four patients had a unilateral aldosterone-producing adenoma, whereas bilateral adrenal hyperplasia was diagnosed in 37 patients. Although at the time of diagnosis the mean potassium values were lower and mean aldosterone levels were higher in patients with an adenoma, as compared to those with bilateral hyperplasia, these laboratory data did not allow us to differentiate between the two leading causes of primary aldosteronism in the individual patient due to pronounced overlap of laboratory values between the two groups. During the first few years, a successful differential diagnosis was made by adrenal phlebography and separate sampling of plasma aldosterone in both adrenal veins; later non-invasive imaging techniques such as computed tomography and radionuclide scanning were used. The best results were obtained in patients with adenoma who underwent adrenalectomy. Fifty-six percent of these patients were clinically and biochemically cured; 28% were improved and had normal blood pressure values during drug treatment. In contrast, patients with bilateral hyperplasia were treated pharmacologically, but only in half of the patients could normal blood pressure values be achieved. Two thirds of the male patients developed gynecomastia during spironolactone treatment. As expected, unilateral adrenalectomy was unsuccessful in the 7 patients with bilateral hyperplasia who underwent surgery. Our results confirm that surgical treatment of adrenal adenomas and drug treatment of bilateral hyperplasias are the appropriate therapy in primary aldosteronism. A differential diagnosis cannot be made on the basis of clinical and non-invasive laboratory data alone; imaging techniques have to be included in the diagnostic process. The long-term clinical outcome was more favorable in patients with an adrenal adenoma that can be removed surgically than in patients with idiopathic hyperplasia of both adrenal glands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

APA:

Aldosterone producing adenoma

IHA:

Idiopathic hyperaldosteronism

References

  1. Auda SP, Brenan MF, Gill JR (1980) Evolution of the surgery management of primary aldosteronism. Ann Surg 191:1–7

    Google Scholar 

  2. Biglieri EG, Kater CE, Arteaga EE (1984) Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma. J Hypertens 2[Suppl 3]: 259–261

    Google Scholar 

  3. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, Vidt DG (1983) The changing clinical spectrum of aldosteronism. Am J Med 74:641–651

    Google Scholar 

  4. Bravo EL, Fouad FM, Tarazi RC, Pohl M, Gifford RW, Vidt DG (1988) Clinical implications of primary aldosteronism with resistant hypertension. Hypertension 11 [Suppl I]: 207–211

    Google Scholar 

  5. Brown JJ, Davies DL, Ferris JB, Fraser R, Haywood, Lever AF, Robertson JIS (1972) Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. BMJ II: 729–734

    Google Scholar 

  6. Clark E (1965) Spironolactone therapy and gynaecomastia. JAMA 193:157–158

    Google Scholar 

  7. Clarke D, Wilkinson R, Johnston IDA, Hacking PM, Haggith JW (1979) Severe hypertension in primary aldosteronism and good response to surgery. Lancet I: 482–485

    Google Scholar 

  8. Conn JW, Knopf RF, Nesbit RM (1964) Clinical characteristics of primary aldosteronism from analysis of 145 cases. Am J Surg 107:159–172

    Google Scholar 

  9. Ferris JB, Brown JJ, Fraser R, Haywood E, Davies DL, Kay AW, Lever AF, Robertson JIS, Owen K, Peart WS (1975) Results of adrenal surgery in patients with hypertension, aldosterone excess, and low renin concentration. BMJ I: 135–138

    Google Scholar 

  10. Ferris JB, Brown JJ, Fraser R, Lever AF, Robertson JIS (1981) Primary hyperaldosteronism. Clin Endocrinol Metab 10:419–452

    Google Scholar 

  11. Ferris JB, Beevers DG, Boody JJ, Davies DL, Fraser R, Kremer D, Lever AF, Robertson JIS (1987) The treatment of low-renin (‘primary’) hyperaldosteronism. Am Heart J 96:729–734

    Google Scholar 

  12. Ganguly A (1982) New insights and questions about glucocorticoid suppressible hyperaldosteronism. Am J Med 67:851–854

    Google Scholar 

  13. Ganguly A, Grim CE, Weinberger MH (1982) Primary aldosteronism. Arch Intern Med 142:813–815

    Google Scholar 

  14. George JM, Wright L, Bell NH, Bartter FC, Brown R (1970) The syndrome of primary aldosteronism. Am J Med 48:343–356

    Google Scholar 

  15. Gordon RD (1989) Update on primary aldosteronism: diagnosis and management. ACE Rep 61:1–8

    Google Scholar 

  16. Grant CL, Carpenter P, Heerden JA van, Hamberger B (1984) Primary aldosteronism. Arch Surg 119:585–590

    Google Scholar 

  17. Greenblatt DJ, Koch J (1973) Adverse reactions to spironolactone. JAMA 225:40–43

    Google Scholar 

  18. Groth H, Vetter W, Stimpel M, Greminger P, Tenschert W, Klaiber E, Vetter H (1985) Adrenalectomy in primary aldosteronism: a long-term follow up study. Cardiology 72 [Suppl 1]: 107–116

    Google Scholar 

  19. Guerin MD, Wahner HW, Gorman CA, Carpenter PC, Sheedy PF (1983) Computed tomographic scanning versus radioisotopic imaging in adrenocortical diagnosis. Am J Med 75:653–657

    Google Scholar 

  20. Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J. Clin Endocr Metab 29:1349–1355

    Google Scholar 

  21. Herwig KR (1979) Primary aldosteronism: experience with thirty eight patients. Surgery 86:470–473

    Google Scholar 

  22. Jeunemaitre X, Chatellier G, Kreft C, Charru A, Devries C, Plouin PF, Corvol P, Menard J (1987) Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60:820–825

    Google Scholar 

  23. Lüscher T, Tenschert W, Salvetti A, Pedrinelli R, Turini F, Maltini G, Vetter H, Vetter W (1984) Primary aldosteronism due to adrenal carcinoma. Klin Wochenschr 62:470–476

    Google Scholar 

  24. Ma JTC, Wang C, Lam KSL, Yeoung RTT, Chan FL, Boey J, Cheung PSY, Coghlan JP, Scoggins BA, Stockigt JR (1986) Fifty cases of primary hyperaldosteronism in Hong Kong Chinese with high frequency of periodic paralysis. Evaluation of techniques for tumor localisation. Q J Med 235:1021–1037

    Google Scholar 

  25. Milsom SR, Espiner EA, Gwynne NJ, Perry EG (1986) The blood pressure response to unilateral adrenalectomy in primary aldosteronism. Q J Med 236:1141–1151

    Google Scholar 

  26. Niewoehner CB, Nutfall FQ (1984) Gynaecomastia in a hospitalised male population. Am J Med 77:633–638

    Google Scholar 

  27. Noth RH, Biglieri EG (1988) Primary aldosteronism. Med Clin North Am 72:1117–1131

    Google Scholar 

  28. Russel RP, Masi AT, Richter ED (1972) Adrenal cortical adenomas and hypertension. Medicine 51:211–225

    Google Scholar 

  29. Saruta T, Suzuki H, Takita T, Saito I, Murai M, Tazaki H (1987) Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism. Acta Endocr (Copenh) 116:229–234

    Google Scholar 

  30. Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG(1976) Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 43:115–131

    Google Scholar 

  31. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JWK (1987) Secondary hypertension in a blood pressure clinic. Arch Intern Med 147:1289–1293

    Google Scholar 

  32. Vetter H, Siebenschein R, Studer A, Witassek F, Furrer J, Glänzer K, Siegenthaler W, Vetter W (1978) Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine and laboratory data and by peripheral aldosterone. Acta Endocr (Copenh) 89:710–725

    Google Scholar 

  33. Vetter H, Fischer M, Galanski M, Stieber U, Tenscher W, Baumgart P, Winterberg B, Vetter W (1985) Primary aldosteronism: Diagnosis and non-invasive lateralization procedures. Cardiology 72 [Suppl I]: 57–63

    Google Scholar 

  34. Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay of aldosterone without chromatography. II. Determination of aldosterone. Acta Endocr (Copenh) 74:558–567

    Google Scholar 

  35. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP (1979) Primary aldosteronism. Ann Intern Med 90:386–391

    Google Scholar 

  36. Young FY, Hagan MJ, Klee GG, Grant CS, Von Heerden J (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65:96–100

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: W Vetter

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeck, T., Weisser, B., Mengden, T. et al. Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands. Clin Investig 72, 979–984 (1994). https://doi.org/10.1007/BF00577740

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00577740

Key words

Navigation